Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria
Recruiting · NCT05916937 · Registry updated 2025-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Recruiting | Phase 4 | 2025-09-19 | NCT05916937 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aarhus University Hospital | 297 |
| Simon Francis Thomsen | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Dermatology, Bispebjerg Hospital | Copenhagen | Denmark | 1 |